Last night in Bilbao was an unforgettable celebration of innovation and impact at the NN Social Innovation Startup Award. Surrounded by inspiring people and groundbreaking ideas, Whispp had the honor of participating alongside exceptional startups such as Bugeto Personal Finance Simulations, ChatLicense, The Linghos, and MEROVA Health Zrt.
The event featured heartfelt and impactful pitches, each addressing critical global challenges. As the audience cast their votes through Mentimeter, their support was palpable. Ultimately, the final decision rested with the jury.
We’re proud to share that Joris Castermans, CEO of Whispp, took the stage as one of the winners, securing €50,000 in funding. This incredible support will help us continue our mission of enabling clear and confident communication for everyone, regardless of voice challenges.
A heartfelt thank you to NN Group, Rubio Impact Ventures, Impact Europe, and the jury for recognizing the potential of Whispp and believing in our vision. To the other finalists—your work inspires us, and it was a privilege to stand alongside you.
Here’s to creating real social impact, together!
Related news
After losing his natural voice to laryngeal cancer, Roger Gillespie found a new way to connect using Whispp. On World Voice Day 2025, we share his story — a reminder of how assistive voice technology can help restore not just speech, but connection, confidence, and joy.
Whispp already received attention in Time Magazine. Now it is also Quote’s turn to interview Joris Castermans about his smart app that ensures that people who are less quick-witted are also heard. But: ‘Eventually only one out of six downloads comes from someone who stutters’.
At 4YFN, Whispp CEO Joris Castermans joined a panel on purpose-driven innovation, sharing how startups like Whispp can create real-world impact. His key message? Technology should break down communication barriers—not build new ones. Discover how Whispp is advancing speech accessibility with real-time voice conversion for people with speech disorders.
